KR102147764B1 - Spingoliposome cosmetic composition with effect of proliferation of skin cells - Google Patents
Spingoliposome cosmetic composition with effect of proliferation of skin cells Download PDFInfo
- Publication number
- KR102147764B1 KR102147764B1 KR1020140025027A KR20140025027A KR102147764B1 KR 102147764 B1 KR102147764 B1 KR 102147764B1 KR 1020140025027 A KR1020140025027 A KR 1020140025027A KR 20140025027 A KR20140025027 A KR 20140025027A KR 102147764 B1 KR102147764 B1 KR 102147764B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- lactic acid
- acid bacteria
- cosmetic composition
- fermented
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Abstract
본 발명은 각종 생리활성성분을 함유하는 스핑고 리포좀 화장료 조성물에 관한 것으로, 더욱 상세하게는 인간줄기세포배양액이나 유산균발효추출물을 활성물질로 함유함으로써 피부세포 증식 효능이 우수한 스핑고 리포좀 화장료 조성물에 관한 것이다. The present invention relates to a sphingo liposome cosmetic composition containing various physiologically active ingredients, and more particularly, to a sphingo liposome cosmetic composition having excellent skin cell proliferation effect by containing human stem cell culture solution or lactic acid bacteria fermentation extract as an active substance. will be.
Description
본 발명은 각종 생리활성성분을 함유하는 스핑고리포좀 화장료 조성물에 관한 것으로, 더욱 상세하게는 인간줄기세포배양액이나 유산균발효추출물을 활성물질로 함유함으로써 피부 세포 증식 효능이 우수한 스핑고리포좀 화장료 조성물에 관한 것이다.
The present invention relates to a sphingoliposome cosmetic composition containing various physiologically active ingredients, and more particularly, to a sphingoliposome cosmetic composition having excellent skin cell proliferation effect by containing human stem cell culture solution or lactic acid bacteria fermentation extract as an active substance. will be.
줄기세포(stem cell)는 발달단계 초기인 배반포기 배의 내부 세포덩어리부터 유래한 배아줄기세포(embryonic stem cells)와 성인 몸의 각 조직에 들어있는 성체줄기세포(adult stem cell)로 나누어지며, 줄기세포 배양액에는 섬유아세포성장인자(fibroblast growth factor ; FGF)와 같은 피부세포 성장 및 재생을 촉진하는 성분이 있는 것으로 알려져 있다(대한민국특허 제10-1032271호). Stem cells are divided into embryonic stem cells derived from the inner cell mass of the blastocyst embryo, which is the early stage of development, and adult stem cells contained in each tissue of the adult body. Stem cell culture media are known to contain components that promote skin cell growth and regeneration, such as fibroblast growth factor (FGF) (Korean Patent No. 10-1032271).
발효는 각종 유해성분을 분해시켜 안전성을 높이고, 소화물 생성 등으로 유효성분 및 흡수율을 증가시키는 것으로 알려져 있는데, 특히 유산균 발효물의 경우 피부보습, 미백효과를 주는 비타민 B1, B2, 판토텐산, B6, 엽산, 탄수화물, 아미노산 및 각종 미네랄이 풍부하며, 발효과정 중에 만들어 지는 당화효소, 프로테아제 등과 같은 각종 천연효소는 유효물질 생성 및 흡수를 높여주어 항산화, 항노화, 미백, 피부보습 등의 효능이 있는 것으로 알려져 있다.Fermentation is known to increase safety by decomposing various harmful ingredients, and to increase the active ingredient and absorption rate by generating digestive products.In particular, in the case of lactic acid bacteria fermentation, vitamins B1, B2, pantothenic acid, B6, folic acid, which provide skin moisturizing and whitening effects, It is rich in carbohydrates, amino acids, and various minerals, and various natural enzymes such as saccharification enzymes and proteases produced during fermentation are known to increase the production and absorption of effective substances, thereby providing antioxidant, anti-aging, whitening, and skin moisturizing effects. .
이러한 유효성분이 피부 세포로 잘 전달되는 것이 중요한데, 화장료의 경우, 소수성 성분과 친수성 성분을 계면활성제 이용하여 가용화나 유화시켜 만드는 것이 일반적이다. 특정 생리활성물질을 피부 세포로 전달효율을 높이기 위해 기술개발이 필요한 실정이다.
It is important that these active ingredients are well delivered to the skin cells. In the case of cosmetics, it is common to solubilize or emulsify a hydrophobic component and a hydrophilic component using a surfactant. Technology development is required to increase the efficiency of delivering specific bioactive substances to skin cells.
이에 본 발명자들은 피부 세포 증식 효능이 뛰어난 화장료를 제조하기 위해 연구하던 중, 유산균 발효시 이소플라본, 사포닌과 같은 유효성분을 함유하는 황기, 콩 등을 첨가하여 제조한 발효추출물이 피부 세포 증식효능이 높은 것을 발견하였고, 이 유산균 발효 추출물이나 인간줄기세포 배양액을 세포막 성분인 스핑고신(spingosine)을 주성분으로 사용하여 스핑고리포좀으로 제조한 화장료 조성물이 인간 피부세포 증식에 우수한 효능이 있는 것을 발견하고 본 발명을 완성하게 되었다.Accordingly, the inventors of the present invention were researching to manufacture a cosmetic with excellent skin cell proliferation effect, and the fermented extract prepared by adding Astragalus, soybean containing active ingredients such as isoflavone and saponin during fermentation of lactic acid bacteria has effective skin cell proliferation. It was found that this lactic acid bacterium fermented extract or human stem cell culture medium was used as a main component of sphingosine, a cell membrane component, and a cosmetic composition made of sphingoliposomes had excellent efficacy in proliferating human skin cells. The invention was completed.
따라서 본 발명의 목적은 인체 피부세포 증식효능이 있는 스핑고리포좀 화장료 조성물을 제공하는 것이다.
Accordingly, it is an object of the present invention to provide a cosmetic composition for sphingoliposomes having a human skin cell proliferation effect.
상기 목적을 달성하기 위하여, 본 발명에서는 황기(Hawanggi)나 콩을 첨가하여 유산균으로 발효시킨 추출물이나 인간 줄기세포 배양액을 유효성분으로 함유하는 스핑고리포좀 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a sphingoliposome cosmetic composition containing as an active ingredient an extract fermented with lactic acid bacteria by adding Hawanggi or soybeans or a human stem cell culture solution.
본 발명에 의한 화장료 조성물은 황기나 콩을 첨가하여 유산균으로 발효시킨 추출물이나 인간 줄기세포 배양액을 유효성분으로 함유하는 스핑고리포좀 조성물로써 높은 피부 세포 증식 효능을 나타낸다.
The cosmetic composition according to the present invention is a sphingoliposome composition containing an extract fermented with lactic acid bacteria by adding Astragalus or soybeans or a human stem cell culture medium as an active ingredient and exhibits high skin cell proliferation efficacy.
도 1은 황기 추출물 함량별 유산균 발효 추출물을 유효성분으로 포함하는 스핑고 리포좀 조성물이 인간 피부섬유아세포(fibroblast)의 증식에 미치는 영향을 조사했을 때에 세포수 증가를 보여주는 그래프이다.
도 2는 유산균 종류별로 발효시킨 유산균 발효 추출물을 유효성분으로 포함하는 스핑고리포좀 조성물이 인간 피부섬유아세포의 증식에 미치는 영향을 조사했을 때에 세포수 증가를 보여주는 그래프이다.1 is a graph showing an increase in the number of cells when a sphingo liposome composition comprising a fermented extract of lactic acid bacteria according to the content of Astragalus extracts as an active ingredient was investigated for the effect on the proliferation of human fibroblasts.
FIG. 2 is a graph showing an increase in the number of cells when a sphingoliposome composition comprising fermented lactic acid bacteria fermented extracts fermented for each type of lactic acid bacteria as an active ingredient was investigated for the proliferation of human skin fibroblasts.
이하, 본 발명을 상세히 설명하면 하기와 같다.Hereinafter, the present invention will be described in detail.
본 발명에서는 1) 인간줄기세포 배양액이나 유산균 발효 추출물을 유효성분으로 준비하는 단계; 및 2) 유효성분을 포함하는 스핑고 리포좀을 만드는 단계를 거쳐 피부세포인 섬유아세포(fibroblast cell) 증식효능을 확인하였다.In the present invention, 1) preparing a human stem cell culture medium or lactic acid bacteria fermented extract as an active ingredient; And 2) through the step of making sphingo liposomes containing an active ingredient, it was confirmed that the proliferation effect of fibroblast cells, which is skin cells.
상기 1) 단계에서, 유효성분으로 인간줄기세포 배양액의 경우, 인간 배아줄기세포나 성체 줄기세포를 배양한 액을 사용한다.
In the above step 1), in the case of a human stem cell culture solution as an active ingredient, a solution obtained by culturing human embryonic stem cells or adult stem cells is used.
상기 1) 단계에서, 유효성분으로 유산균 발효 추출물의 경우, 황기나 콩을 첨가하여 유산균으로 발효시켜 추출하여 사용한다. 유산균의 경우 락토바실러스 비피덤(Lactobacillus bifidum)을 비롯한 락토바실러스계 유산균이나 스트렙토코커스 더모필러스(Streptococcus thermopilus)를 비롯한 스트렙토코커스계 유산균 그룹에서 선택된 1종 단독으로 또는 2종 이상 혼합물로 사용할 수 있다. 유산균 발효는 우유, 포도당, 이스트추출물(yeast extract)을 함유하는 배지를 기본배지로 하여 황기나 콩은 정제수, 에탄올 중 1종 또는 2종 혼합하여 추출한 추출물을 1 중량% 내지 99 중량% 사이를 첨가하여 사용하며, 바람직하게는 25 중량% 내지 75 중량% 사이를 첨가하여 사용하며, 가장 바람직하게는 50 중량% 내지 75 중량% 사이를 첨가하여 사용한다. 황기나 콩의 추출온도는 10℃ 내지 121℃사이가 바람직하며, 15분 내지 24시간 사이 동안 추출할 수 있다. 기본 배지에 황기나 콩 추출물 첨가하여 유산균을 접종하여 4℃ 내지 40℃ 사이에서 충분한 발효가 일어날 수 있도록 1일에서 1년 사이 정도, 바람직하게는 2일간 발효시킨다. 발효액을 추출하는 용매로는 정제수, 1,3-부틸렌글리콜(1,3- butylene glycol), 에탄올, 글리세린으로 이루어진 그룹에서 선택된 1종을 단독으로 또는 2종 이상 혼합하여 사용할 수 있으며, 추출온도는 10℃ 내지 121℃ 사이가 바람직하며, 15분 내지 24시간 사이 동안 추출할 수 있다. In the above step 1), in the case of the fermented extract of lactic acid bacteria as an active ingredient, astragalus or soybeans are added and fermented with lactic acid bacteria to be extracted and used. In the case of lactic acid bacteria, Lactobacillus bifidum , including Lactobacillus-based lactic acid bacteria or Streptococcus thermopilus , may be used alone or in a mixture of two or more. Lactobacillus fermentation uses a medium containing milk, glucose, and yeast extract as the basic medium, and adds between 1% to 99% by weight of the extract extracted by mixing one or two types of purified water and ethanol for Astragalus or soybeans. It is used by adding, preferably between 25% by weight and 75% by weight, and most preferably between 50% by weight and 75% by weight. The extraction temperature of Astragalus or soybeans is preferably between 10°C and 121°C, and can be extracted for 15 minutes to 24 hours. Astragalus or soybean extract is added to the basic medium to inoculate lactic acid bacteria and fermented for about 1 to 1 year, preferably for 2 days, so that sufficient fermentation can occur between 4°C and 40°C. As a solvent for extracting the fermentation broth, one selected from the group consisting of purified water, 1,3-butylene glycol, ethanol, and glycerin may be used alone or in combination of two or more. Is preferably between 10 ℃ and 121 ℃, it can be extracted for between 15 minutes to 24 hours.
상기 2) 단계에서, 스핑고신(spingosine), 레시틴, 글리세린을 혼합한다. 이들의 중량비는 순서대로 각각 1~10 : 1~10 :1~10 이며, 가장 바람직하게는 5: 3: 2이다. 혼합물은 70℃ 내지 80℃사이에서 20분 내지 30분 사이 동안 가열하며 교반한다. 교반하여 준비된 혼합물에 상기 1) 단계에서 준비된 인간줄기세포배양액이나 유산균 발효추출물을 10 중량% 내지 99 중량% 사이로 첨가하여 제조한다. In step 2) above, spingosine, lecithin, and glycerin are mixed. Their weight ratio is 1-10:1-10:1-10, respectively, in order, and most preferably 5: 3:2. The mixture is heated and stirred between 70° C. and 80° C. for 20 to 30 minutes. It is prepared by adding between 10% by weight to 99% by weight of the human stem cell culture solution or the lactic acid bacteria fermentation extract prepared in step 1) to the mixture prepared by stirring.
이하, 본 발명은 비한정적인 실시예를 통해 상세히 설명한다.
Hereinafter, the present invention will be described in detail through non-limiting examples.
(실시예1) 황기추출물의 제조 (Example 1) Preparation of Astragalus extract
제천산 황기 1kg을 정제수로 세척한 후, 10배의 정제수를 첨가하여 121℃에서 15분간 가열한다. 상온에 방치시켜 온도를 40℃이하로 낮추고 종이 여과지를 사용하여 감압 여과하여 여과지를 통과한 황기추출물을 제조하였다.
After washing 1 kg of Jecheon-san Hwanggi with purified water, 10 times of purified water is added and heated at 121°C for 15 minutes. It was allowed to stand at room temperature, the temperature was lowered to 40°C or less, and filtered under reduced pressure using a paper filter paper to prepare an Astragalus extract that passed through the filter paper.
(실시예2) 황기 추출물을 첨가한 유산균 발효 추출물 제조(Example 2) Preparation of lactic acid bacterium fermented extract containing Astragalus extract
발효에 사용된 유산균은 A, B, C 그룹으로 진행하였다. 유산균 A 그룹은 스트렙토코커스 더모필러스(Streptococcus thermopilus), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 페르멘텀(Lactobacillus fermentum)의 3종류가 포함되며, 유산균 B 그룹은 락토바실러스 비피덤(Lactobacillus bifidum)을 사용하였고, 유산균 C 그룹은 락토바실러스 아시도필러스(Lactobacillus acidophilus), 락토바실러스 카세이(Lactobacillus casei), 락토바실러스 글란타럼(Lactobacillus plantarum), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 스트렙토코커스 더모필러스(Streptococcus thermopilus) 5가지를 혼합하여 사용하였다. 우유 20 중량%, 포도당 2 중량%, 이스트추출물(yeast extract) 0.3 중량%를 기본 배지로 하여 상기 실시예 1에서 준비한 배지 중량 %에 대하여, 황기추출물을 25 중량%, 50 중량%, 75 중량%로 각각 첨가하여 나머지를 정제수로 100 중량%가 되도록 맞추어 준비한 배지에 상기 유산균 A, B, C 그룹 유산균을 배지 중량에 대하여 0.1 중량%씩 접종하여 36℃에서 48시간 동안 발효시켰다. 발효액에 동일한 비율의 정제수를 첨가하여 종이 여과지를 사용하여 감압 여과하여 여과지를 통과한 유산균 발효 추출물 제조하였다.Lactic acid bacteria used in fermentation proceeded to groups A, B, and C. Lactobacillus A group includes three types of Streptococcus thermopilus , Lactobacillus bulgaricus , and Lactobacillus fermentum , and Lactobacillus bifidum B group is Lactobacillus bifidum . Lactobacillus acidophilus ( Lactobacillus acidophilus ), Lactobacillus casei , Lactobacillus plantarum ( Lactobacillus plantarum ), Lactobacillus bulgaricus ( Lactobacillus bulgaricus dermophilus ) Rus ( Streptococcus thermopilus ) 5 kinds were mixed and used. With respect to the weight of the medium prepared in Example 1 using 20% by weight of milk, 2% by weight of glucose, and 0.3% by weight of yeast extract as a basic medium, the Astragalus extract was 25% by weight, 50% by weight, and 75% by weight. The lactic acid bacteria A, B, and C group lactic acid bacteria were inoculated at 0.1% by weight based on the weight of the medium in a medium prepared by adding the remainder to 100% by weight with purified water and fermented at 36°C for 48 hours. Purified water in the same ratio was added to the fermentation broth, filtered under reduced pressure using paper filter paper, and passed through the filter paper to prepare a fermented extract of lactic acid bacteria.
(실시예3) 유산균 발효 추출물을 유효성분으로 포함하는 스핑고 리포좀 제조(Example 3) Preparation of sphingo liposomes containing fermented extract of lactic acid bacteria as an active ingredient
피토스핑고신(phytospingosine) 50g, 레시틴 30g, 글리세린 20g을 혼합하여 75℃ 에서 25분 동안 가열하며 교반한다. 교반하여 준비된 혼합물을 상기 실시예 2에서 준비된 유산균 발효 추출물 900g에 200rpm 속도로 20분간 교반하며 첨가하고 제조하였다. 50g of phytospingosine, 30g of lecithin, and 20g of glycerin were mixed and stirred while heating at 75°C for 25 minutes. The mixture prepared by stirring was added to 900 g of the lactic acid bacteria fermented extract prepared in Example 2 with stirring at 200 rpm for 20 minutes, and prepared.
(실시예4) 인간줄기세포 배양액을 유효성분으로 포함하는 스핑고 리포좀 제조(Example 4) Preparation of sphingo liposomes containing human stem cell culture medium as an active ingredient
상기 실시예3 에서 유산균 발효 추출물 대신 인간줄기세포 배양액 900g을 상기 실시예 3과 같은 방법으로 사용하여 제조하였다.
Instead of the lactic acid bacteria fermented extract in Example 3, 900 g of human stem cell culture solution was prepared in the same manner as in Example 3.
(실시예5) 유산균 발효 추출물을 유효성분으로 포함하는 스핑고 리포좀 조성물이 인간 피부섬유아세포의 증식에 미치는 영향(Example 5) Effect of sphingo liposome composition containing fermented lactic acid bacteria extract as an active ingredient on proliferation of human skin fibroblasts
피부의 진피층에 존재하여 콜라겐을 형성하는 인간 피부섬유아세포를 8% FBS가 첨가된 DMEM(Gibco) 유지 배양액으로 배양한 다음, 96웰 플레이트에 10000개씩 넣어주고 여기에 실시예 3에서 제조한 스핑고 리포좀 조성물을 첨가하여 72시간 동안 배양하였다. 각 웰에 EZ-Cytox(Enhanced cell viability assay kit) 용액을 10μl씩 첨가하고 1시간 후 450nm에서 흡광도를 측정하였다. Human dermal fibroblasts that exist in the dermal layer of the skin to form collagen were cultured with DMEM (Gibco) maintenance culture solution added with 8% FBS, and then 10000 pieces were added to 96-well plates, and the sphingo prepared in Example 3 The liposome composition was added and incubated for 72 hours. 10 μl of EZ-Cytox (Enhanced cell viability assay kit) solution was added to each well, and absorbance was measured at 450 nm after 1 hour.
도 1는 황기 추출물 함량별 유산균 발효 추출물을 유효성분으로 포함하는 스핑고 리포좀 조성물이 인간 피부섬유아세포의 증식에 미치는 영향을 조사한 결과로써, 황기 추출물 첨가량이 25 중량% 내지 75 중량% 사이에서 모두 양성대조군으로 사용한 아스코르빈산 보다 30%이상 높은 세포수 증가를 보여주는 그래프이다. 1 is a result of investigating the effect of a sphingo liposome composition containing a fermented extract of lactic acid bacteria according to the amount of Astragalus extract as an active ingredient on the proliferation of human skin fibroblasts. This is a graph showing an increase in the number of cells that is more than 30% higher than ascorbic acid used as a control.
도 2는 유산균 종류별로 발효시킨 유산균 발효 추출물을 유효성분으로 포함하는 스핑고 리포좀 조성물이 인간 피부섬유아세포의 증식에 미치는 영향을 조사한 결과로써, 모두 양성대조군으로 사용한 아스코르빈산 보다 30%이상 높은 세포수 증가를 보여주었고 특히 B 그룹인 락토바실러스 비피덤(Lactobacillus bifidum)으로 발효시킨 유산균 발효 추출을 유효성분으로 포함하는 스핑고 리포좀 조성물이 가장 높은 세포수 증가를 보여주는 그래프이다.Figure 2 is a result of investigating the effect of the sphingo liposome composition containing fermented lactic acid bacteria fermented extracts fermented for each type of lactic acid bacteria as an active ingredient on the proliferation of human skin fibroblasts, all cells higher than 30% of ascorbic acid used as a positive control It showed an increase in the number, and in particular, a sphingo-liposome composition containing a fermented extract of lactic acid bacteria fermented with Lactobacillus bifidum , a group B, as an active ingredient, is a graph showing the highest increase in cell number.
(실시예6) 인간줄기세포 배양액을 유효성분으로 포함하는 스핑고 리포좀 함유 크림 제형 화장료 제조(Example 6) Preparation of a cream formulation cosmetic containing sphingo liposomes containing human stem cell culture medium as an active ingredient
정제수 26.46g, 인간 줄기세포 배양액 함유 스핑고 리포좀 10g, 사이클로펜타실록산 1g, 피이지/피피지-18/18디메치콘 1g, 부틸렌글라이콜 1g, 나이아신아마이드 5g, 디페닐실록시페닐트리메치콘 1g, 디메치콘/비닐디메치콘크로스폴리머 1g, 디메치콘 1g, 소듐클로라이드 1g, 세필피이지/피피지-10/1디메치콘 1g, 아세틸헥사펩타이드-8 1g, 인삼캘러스배양추출물 1g, 황금캘러스배양액 1g, 배초향캘러스배양액 1g, 장뇌삼추출물 1g, 하이드롤라이즈드태반추출물 1g, 접시꽃뿌리추출물 1g, 알로에베라잎추출물 1g, 알에이치-폴리펩나이드-7 1g, 에스에이치-올리고펩타이드- 1 1g, 카퍼트리펩타이드-1 1g, 에스에이치-폴리펩타이드-2 1g, 올리고펩타이드-28 1g, 올리고펩타이드-29 1g, 올리고펩타이드-30 1g, 올리고펩타이드-31 1g, 에스에이치-데카펩타이드-7 1g, 에스에이치-데카펩타이드 1g, 에스에이치-올리고펩타이드 -9 1g, 에스에이치-펜타펩타이드-19 1g, 옥타펩타이드-7 1g, 데카펩타이드-6 1g, 프로폴리스추출물 1g, 아사이야자추출물 1g, 락토바실러스/콩발효추출물 1g, 화이트윌로우껍질추출물 1g, 육계추출물 1g, 오레가노잎추출물 1g, 편백나무잎추출물 1g, 황금추출물 1g, 마치현추출물 1g, 알라닌 1g, 글라이신 1g, 알지닌 1g, 세린 1g, 류신 1g, 이소류신 1g, 디포타슘글리시리제이트 1g, 알로에베라잎즙가루 1g, 아데노신 0.04g, 병풀추출물 1g, 팔각회향추출물 1g, 토코페릴아세테이트 1g, 소르비탄세스퀴올리에이트 1g, 카프릴릴글라이콜 1g, 1,2-헥산디올 1g, 디소듐이디티에이 1g, 소듐하이알루로네이트 1g, 알란토인 1g, 향료 0.5g으로 혼합하여 제조하였다.
Purified water 26.46g, human stem cell culture medium containing sphingo-liposome 10g, cyclopentasiloxane 1g, PEG/PP-18/18 dimethicone 1g, butylene glycol 1g, niacinamide 5g, diphenylsiloxyphenyltrimethicone 1g, Dimethicone/Vinyl Dimethicone Crosspolymer 1g, Dimethicone 1g, Sodium Chloride 1g, Sepil PEG/PP-10/1 Dimethicone 1g, Acetylhexapeptide-8 1g, Ginseng Callus Culture Extract 1g, Golden Callus Culture Solution 1g, baecho flavor callus culture solution 1g, camphor ginseng extract 1g, hydrolyzed placenta extract 1g, hollyhock root extract 1g, aloe vera leaf extract 1g, RH-polypepnide-7 1g, SH-oligopeptide-1 1g, copper tree Peptide-1 1g, SH-polypeptide-2 1g, Oligopeptide-28 1g, Oligopeptide-29 1g, Oligopeptide-30 1g, Oligopeptide-31 1g, SH-decapeptide-7 1g, SH-decapeptide 1g , SH-oligopeptide -9 1g, SH-pentapeptide-19 1g, Octapeptide-7 1g, Decapeptide-6 1g, Propolis extract 1g, Acaija extract 1g, Lactobacillus/bean fermentation extract 1g, White willow peel Extract 1g, Broiler Extract 1g, Oregano Leaf Extract 1g, Cypress Tree Leaf Extract 1g, Golden Extract 1g, Portulaca oleracea extract 1g, Alanine 1g, Glycine 1g, Arginine 1g, Serine 1g, Leucine 1g, Isoleucine 1g, Dipotassium Glycyrrhase Thurs 1g, Aloe Vera Leaf Juice Powder 1g, Adenosine 0.04g, Centellar Extract 1g, Octagonal Fennel Extract 1g, Tocopheryl Acetate 1g, Sorbitan Sesquioleate 1g, Caprylyl Glycol 1g, 1,2-hexanediol 1g, It was prepared by mixing 1 g of disodium EDTA, 1 g of sodium hyaluronate, 1 g of allantoin, and 0.5 g of fragrance.
Claims (4)
상기 혼합물은 스핑고신, 레시틴 및 글리세린이 5:3:2 의 중량비로 혼합된 것이며,
상기 유산균 발효추출물은 황기 추출물을 25~75 중량% 첨가하여 락토바실러스 비피덤(Lactobacillus bifidum)으로 발효시킨 것을 특징으로 하는 주름개선용 화장료 조성물.
Contains sphingo liposomes prepared by stirring and adding a mixture of spingosine, lecithin, and glycerin to the fermented extract of lactic acid bacteria,
The mixture is a mixture of sphingosine, lecithin and glycerin in a weight ratio of 5:3:2,
The lactic acid bacteria fermented extract is a cosmetic composition for improving wrinkles, characterized in that fermented with Lactobacillus bifidum by adding 25 to 75% by weight of Astragalus extract.
상기 화장료 조성물은,
현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 왁스 또는 스프레이의 제형을 갖는 것을 특징으로 하는 주름개선용 화장료 조성물.The method of claim 1,
The cosmetic composition,
A cosmetic composition for improving wrinkles, characterized in that it has a formulation of suspension, emulsion, paste, gel, cream, lotion, powder, wax or spray.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140025027A KR102147764B1 (en) | 2014-03-03 | 2014-03-03 | Spingoliposome cosmetic composition with effect of proliferation of skin cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140025027A KR102147764B1 (en) | 2014-03-03 | 2014-03-03 | Spingoliposome cosmetic composition with effect of proliferation of skin cells |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150103503A KR20150103503A (en) | 2015-09-11 |
KR102147764B1 true KR102147764B1 (en) | 2020-08-26 |
Family
ID=54243688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140025027A KR102147764B1 (en) | 2014-03-03 | 2014-03-03 | Spingoliposome cosmetic composition with effect of proliferation of skin cells |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102147764B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101787319B1 (en) * | 2017-04-03 | 2017-10-18 | 연세대학교 산학협력단 | Composition comprising Cinchonine or as active ingredients for anti-wrinkle, skin moisturizing, improving skin elasticity, exfoliating, inhibiting erythema or improving skin photo-aging |
KR101998310B1 (en) | 2017-10-31 | 2019-07-09 | 훠리스트 주식회사 | Fast releasing micellar nanoparticle and a cosmetic composition comprising it |
KR102283326B1 (en) * | 2019-05-27 | 2021-07-29 | 주식회사 단정바이오 | Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101237430B1 (en) | 2008-05-07 | 2013-02-26 | 남명진 | A cosmetic composition comprising stem cell culture medium and a process for producing the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101068815B1 (en) * | 2008-08-12 | 2011-10-04 | 두두원발효(주) | Cosmetic composition for improving skin wrinkle and skin whitening comprising a soybean compound fermented by kimchi lactic acid bacteria complex |
KR101321346B1 (en) * | 2011-06-02 | 2013-10-22 | 파미셀 주식회사 | Cosmetic Composition comprising human stem cell conditioned media extracts in supercritical liposome as Active Ingredient |
KR20140002577A (en) * | 2013-11-22 | 2014-01-08 | 서울향료주식회사 | Compostion for reducing irritation and infla㎜aion in skin comprising extracts of Astragalus membranaceus |
-
2014
- 2014-03-03 KR KR1020140025027A patent/KR102147764B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101237430B1 (en) | 2008-05-07 | 2013-02-26 | 남명진 | A cosmetic composition comprising stem cell culture medium and a process for producing the same |
Also Published As
Publication number | Publication date |
---|---|
KR20150103503A (en) | 2015-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20080094457A (en) | Anti-wrinkle cosmetic composition | |
KR20140052576A (en) | Prebiotic cosmetic composition having plant fermentation extract | |
CN105722974B (en) | Method for inducing totipotent stem cells, and totipotent stem cells prepared by the method | |
TWI668009B (en) | Skin external agent for skin whitening comprising an extract of fermented wheat germ | |
JP6927660B2 (en) | Topical skin composition and oral composition | |
CN101431980B (en) | Fermented product composition, cosmetic composition and method of producing the same | |
CN108096146A (en) | With whitening and anti-aging, the rose enzyme of anti-inflammatory effect and its application in cosmetics | |
KR102147764B1 (en) | Spingoliposome cosmetic composition with effect of proliferation of skin cells | |
KR20200049122A (en) | Anti-aging composition comprising functional peptides and fermented products | |
TWI601540B (en) | Human Skin Epidermal Cell Proliferator, Compositions Containing Its Skin, and Cosmetic Ingredients | |
KR20190063549A (en) | Cosmetic Composition Comprising Bamboo Fermented Extract | |
KR101988829B1 (en) | Composition for improving skin elasticity and female breast expansion | |
KR101988830B1 (en) | Composition for moisturizing, improving skin elasticity, and female breast expansion | |
KR101790185B1 (en) | Cosmetic composition containing extracting fraction of fermented beans as an active ingredient | |
JP6326413B2 (en) | Pentosidine production inhibitor | |
JP6951908B2 (en) | Topical skin agent | |
CN105602765A (en) | Skin whitening and moisturizing skin care soap and preparation method thereof | |
TWI701033B (en) | Bundling energy enhancer of collagen fiber | |
KR101666783B1 (en) | Cosmetic composition comprising fermentates of herbal medicine fruits improving whitening and antioxidation | |
JP6475475B2 (en) | Collagen production promoter | |
KR102157210B1 (en) | The functional cosmetic composition comprising extract of natural micro organism-fermented black ginseng | |
JP2021172593A (en) | External preparation for skin | |
JP7233832B2 (en) | hair cosmetics | |
KR102578086B1 (en) | Method of Preparing Bambusa vulgaris Leaf Fermentation Extract And Cosmetic Composition Containing the Fermentation Extract for Skin Moisturizing | |
KR20160087507A (en) | cosmetic composition containing Phaseolus Radiatus Seed, Phaseolus Vulgaris (Kidney Bean) Seed and Black Soybean extracts by fermentation and enzyme treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |